18 May 2007

Vantage Diagnostics to appoint Dr. Angela Hetherington as its new Clinical Director

Vantage Diagnostics is pleased to announce Dr Angela Hetherington as its new Clinical Director. An Organisational Psychologist, Angela has an intensive first hand experience of clinical governance, project management, change management and consultancy in the healthcare industry in both the private and public sector, including BUPA, Netcare, Nuffield Healthcare and Nikko PLC. Angela is or was recently a Board Director, Clinical Director and/or Operations Director of several international healthcare companies, with specific responsibility for clinical governance.

Dr Hetherington has worked with the Department of Health and the Independent Sector Treatment Centres (ISTC), negotiating with the Royal Colleges, Deaneries, Higher Education Institutions, and professional and regulatory bodies in the transfer of service and medical training from the NHS to the IS. Angela will be responsible for ensuring that Vantage Diagnostics maintains the highest standards of Clinical Governance across all telehealth products. As a highly regarded clinician,

Angela will interact with the Company’s medical consultants, referring clinicians, patients and customers.

About Vantage Diagnostics:

Vantage Diagnostics is a London based telehealth company developed to provide evolutionary telecardiology and teledermatology to the UK healthcare market. Our solutions are in service within the NHS and Independent Sector across the UK. Using proven technology linking patients to remote consultant cardiologists and dermatologists and employing innovative patient care pathways. Our clinical solutions further extend Primary Care referral, diagnostic, and treatment provision. For more information please call 0207 268 3034 or visit www.vantagediagnostics.com